MERRIMACK PHARMACEUTICALS INC Increase (Decrease) in Restricted Cash
MERRIMACK PHARMACEUTICALS INC reported Increase (Decrease) in Restricted Cash of $60.01 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-08.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-11-08
- MERRIMACK PHARMACEUTICALS INC increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month |
|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $60.01M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $60.01M 10-Q · filed 2017-08-09 |